PUBLISHER: The Business Research Company | PRODUCT CODE: 1829935
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829935
A microtome is a laboratory instrument designed to cut thin sections of materials, particularly biological tissue, for microscopic analysis. This device ensures the precise and uniform slicing of samples, allowing for high-quality imaging and accurate examination under a microscope.
The primary product categories of microtomes include instruments and accessories. Microtome instruments are specialized devices used to cut thin slices of biological samples for microscopic study. These instruments utilize various technologies, such as fully automated, semi-automated, and manual, for applications including disease diagnosis and medical research. They are used by a range of end-users, including hospitals, clinical and diagnostic laboratories, academic research centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The microtomes market research report is one of a series of new reports from The Business Research Company that provides microtomes market statistics, including the microtomes industry global market size, regional shares, competitors with the microtomes market share, detailed microtomes market segments, market trends, and opportunities, and any further data you may need to thrive in the microtomes industry. This microtomes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microtome market size has grown strongly in recent years. It will grow from $0.24 billion in 2024 to $0.26 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising awareness about the early diagnosis, increasing demand for biopsies, increasing geriatric population, increasing demand for microtomes, and growing prevalence of cancer.
The microtome market size is expected to see strong growth in the next few years. It will grow to $0.33 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the rising prevalence of chronic diseases, an increase in the elderly population, a growing prevalence of oncological disorders, a rising adoption of microtomes in the field of neuroscience, and the growth of precision medicine. Major trends in the forecast period include advancements in automation, motorized microtomes with programmable features, the introduction of diamond-coated blades, integration with imaging systems, and development in high-resolution sectioning.
The forecast of 6.4% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on precision-ground steel blades from Japan, increasing costs for tissue sectioning equipment and potentially delaying pathological diagnoses in cancer and research laboratories.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of oncological disorders is expected to drive the growth of the microtome market in the coming years. Oncological disorders encompass diseases characterized by the uncontrolled growth and spread of abnormal cells, often resulting in cancer. Several factors contribute to the rising prevalence of these disorders, including an aging population, greater exposure to environmental carcinogens, unhealthy lifestyles, and genetic predispositions. Microtomes play a crucial role in pathology by enabling precise tissue slicing, allowing for the examination of cancerous cells and the determination of tumor type and progression. For instance, in February 2024, the World Health Organization, an international public health organization based in Switzerland, reported that nearly 20 million new cancer cases were recorded in 2022, leading to approximately 10 million deaths. Projections indicate that the annual incidence of cancer could increase to 35 million by 2050, representing a 77% rise from 2022 figures. As a result, the growing prevalence of oncological disorders is fueling the expansion of the microtome market.
Leading companies in the microtome market are concentrating on the development of advanced tissue sectioning devices to enhance efficiency in laboratory settings and improve outcomes in both clinical and research environments. Tissue sectioning devices are essential laboratory tools that produce precise, uniform tissue slices for histology, research, and diagnostics. For example, in February 2023, Precisionary Instruments, a US-based microtome manufacturer, introduced a new line of rotary microtomes. These models feature a heavy, stable core ideal for serial sectioning, ensuring consistent results with large sample sizes. The RF-600 manual model includes two specimen clamp holders for different cassette sizes, while the RF-800 and RF-1000 models incorporate LCD touchscreen controls. The RF-1000 model also offers fully automated cutting capabilities, which can be operated via touchscreen, control panel, or foot pedal for enhanced efficiency. These microtomes are particularly well-suited for sectioning paraffin-embedded tissue in histology studies.
In January 2023, Green Leaf Scientific, an Ireland-based provider of laboratory tools and research instruments, partnered with Precisionary Instruments LLC to introduce tissue sectioning equipment to life science laboratories across Europe. This collaboration aims to integrate Precisionary's advanced tissue-slicing solutions with Green Leaf Scientific's sales expertise, customer service, and local market knowledge to foster growth and advance tissue slice research in Europe. Precisionary Instruments LLC is a US-based company specializing in the design and manufacturing of tissue slicers and microtomes.
Major players in the microtome market are Cardinal Health Inc., Leica Biosystems Nussloch GmbH, Sakura Finetek Inc., RWD Life Science Co. Ltd., SM Scientific Instruments Pvt. Ltd., Narang Medical Limited, AGD Biomedicals Pvt. Ltd., Diapath S.p.A., Milestone Medical, Boeckeler Instruments Inc., SLEE Medical GmbH, microTec Laborgerate GmbH, Campden Instruments, Precisionary Instruments LLC, Jinhua YIDI Medical Appliance Co. Ltd., Medimeas, Histo-Line Laboratories, MEDITE Medical GmbH, Erma Inc., CellPath Ltd., Laboid International.
North America was the largest region in the microtome market in 2024. The regions covered in microtome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the microtome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The microtome market consists of sales of sliding microtomes, cryostat microtomes, sledge microtomes, and ultra microtomes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microtome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on microtome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microtome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microtome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.